Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotinamide in Friedreich Ataxia (NICOFA)
NCT03761511Phase 2Withdrawn
- Sponsor
- RWTH Aachen University
- Start
- Apr 2023
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 6
01
Overview
Phase 2, randomised, double-blind trial in Friedreich ataxia (FA) comparing Nicotinamide Arm with Placebo Arm (2 arms). Primary endpoint: Scale for the Assessment and Rating of Ataxia at 1 year. Planned start Apr 2023; status: withdrawn.
02
Drugs
nicotinamide
03
Conditions
Friedreich ataxia (FA)
Beyond the preview
Go deeper on NCT03761511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03761511.